For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy(R) and Ozempic(R) for only $199 each beginning November 17, 2025 -- Also effective November 17, ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...
Over the course of the patient's treatment, there were opportunities to recognize the error and prevent the patient's catastrophic results.
News-Medical.Net on MSN
Novel triple receptor agonist shows potent efficacy in lowering high triglycerides
In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients ...
In addition, patients treated with DR10624 had a 63% reduction in liver fat, which is important because many people with ...
Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBrian Luque - Head of Investor Relations & ...
Families across the UK face long NHS delays for ADHD assessments, forcing many to pay thousands for private care.
Novo Nordisk today announced that Wegovy® (semaglutide) injection 0.25 mg and 0.5 mg and Ozempic® are now available at a limited time price of $199 per month to new self-pay patients between now and ...
Q3 2025 revenue of €143.1 million for YORVIPATH® and €50.7 million for SKYTROFA® – Q3 2025 operating profit of €11.0 million – TransCon® CNP (navepegritide) under FDA Priority Review for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results